Clinical Research Services Market by Services (Clinical Trials, Diagnostic Research, Drug Development Consultancy), Indication (Cardio Vascular Disorders, CNS Disorders, Diabetes), End-User, Deployment - Global Forecast 2024-2030

Clinical Research Services Market by Services (Clinical Trials, Diagnostic Research, Drug Development Consultancy), Indication (Cardio Vascular Disorders, CNS Disorders, Diabetes), End-User, Deployment - Global Forecast 2024-2030


The Clinical Research Services Market size was estimated at USD 57.31 billion in 2023 and expected to reach USD 62.69 billion in 2024, at a CAGR 9.47% to reach USD 108.02 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Research Services Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Research Services Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Research Services Market, highlighting leading vendors and their innovative profiles. These include Ardent CRO, Azelix, BIO Agile Therapeutics, Charles River Laboratories, CROISSANCE CLINICAL RESEARCH, Dove Quality Solutions, Firma Clinical Research, Icon PLC, IQVIA, Laboratory Corporation of America, Medpace Holdings, Parexel International Corporation, PSI CRO AG, SGS SA, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage


This research report categorizes the Clinical Research Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

Services
Clinical Trials
Diagnostic Research
Drug Development Consultancy
Epidemiological Studies
Genetic Studies
Preclinical Studies
Prevention Research
Quality of Life Research
Screening Research
Treatment Research
Indication
Cardio Vascular Disorders
CNS Disorders
Diabetes
Infectious Diseases
Oncology
End-User
Advance Pathologies
Contract Research Organizations
Medical Device Companies
Pharmaceutical & Biopharmaceutical Companies
Deployment
In-House
Outsource
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Clinical Research Services Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Research Services Market?
3. What are the technology trends and regulatory frameworks in the Clinical Research Services Market?
4. What is the market share of the leading vendors in the Clinical Research Services Market?
5. Which modes and strategic moves are suitable for entering the Clinical Research Services Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Clinical Research Services Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid technological advancements and growing globalization encouraging biotech and pharmaceutical companies
5.1.1.2. Demand for effective drugs and healthcare devices
5.1.1.3. Surging patient population
5.1.2. Restraints
5.1.2.1. High cost associated with product development
5.1.3. Opportunities
5.1.3.1. Increasing investment in research & development activities
5.1.3.2. Expanding strategic collaboration among companies
5.1.4. Challenges
5.1.4.1. Stringent drug approval process
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Clinical Research Services Market, by Services
6.1. Introduction
6.2. Clinical Trials
6.3. Diagnostic Research
6.4. Drug Development Consultancy
6.5. Epidemiological Studies
6.6. Genetic Studies
6.7. Preclinical Studies
6.8. Prevention Research
6.9. Quality of Life Research
6.10. Screening Research
6.11. Treatment Research
7. Clinical Research Services Market, by Indication
7.1. Introduction
7.2. Cardio Vascular Disorders
7.3. CNS Disorders
7.4. Diabetes
7.5. Infectious Diseases
7.6. Oncology
8. Clinical Research Services Market, by End-User
8.1. Introduction
8.2. Advance Pathologies
8.3. Contract Research Organizations
8.4. Medical Device Companies
8.5. Pharmaceutical & Biopharmaceutical Companies
9. Clinical Research Services Market, by Deployment
9.1. Introduction
9.2. In-House
9.3. Outsource
10. Americas Clinical Research Services Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Clinical Research Services Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Clinical Research Services Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Ardent CRO
14.1.2. Azelix
14.1.3. BIO Agile Therapeutics
14.1.4. Charles River Laboratories
14.1.5. CROISSANCE CLINICAL RESEARCH
14.1.6. Dove Quality Solutions
14.1.7. Firma Clinical Research
14.1.8. Icon PLC
14.1.9. IQVIA
14.1.10. Laboratory Corporation of America
14.1.11. Medpace Holdings
14.1.12. Parexel International Corporation
14.1.13. PSI CRO AG
14.1.14. SGS SA
14.1.15. Thermo Fisher Scientific Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. CLINICAL RESEARCH SERVICES MARKET RESEARCH PROCESS
FIGURE 2. CLINICAL RESEARCH SERVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. CLINICAL RESEARCH SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CLINICAL RESEARCH SERVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CLINICAL RESEARCH SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CLINICAL RESEARCH SERVICES MARKET DYNAMICS
FIGURE 7. CLINICAL RESEARCH SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 8. CLINICAL RESEARCH SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CLINICAL RESEARCH SERVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. CLINICAL RESEARCH SERVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CLINICAL RESEARCH SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. CLINICAL RESEARCH SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CLINICAL RESEARCH SERVICES MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
FIGURE 14. CLINICAL RESEARCH SERVICES MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CLINICAL RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CLINICAL RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CLINICAL RESEARCH SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CLINICAL RESEARCH SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CLINICAL RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CLINICAL RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CLINICAL RESEARCH SERVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. CLINICAL RESEARCH SERVICES MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings